Danaher (FRA:DAP) FCF Margin % : 24.98% (As of Mar. 2024)

View and export this data going back to 1986. Start your Free Trial

What is Danaher FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Danaher's Free Cash Flow for the three months ended in Mar. 2024 was €1,332 Mil. Danaher's Revenue for the three months ended in Mar. 2024 was €5,332 Mil. Therefore, Danaher's FCF Margin % for the quarter that ended in Mar. 2024 was 24.98%.

As of today, Danaher's current FCF Yield % is 3.04%.

The historical rank and industry rank for Danaher's FCF Margin % or its related term are showing as below:

FRA:DAP' s FCF Margin % Range Over the Past 10 Years
Min: 17.37 Med: 23.5 Max: 28.7
Current: 24.59

During the past 13 years, the highest FCF Margin % of Danaher was 28.70%. The lowest was 17.37%. And the median was 23.50%.

FRA:DAP's FCF Margin % is ranked better than
93.3% of 224 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.51 vs FRA:DAP: 24.59

Danaher FCF Margin % Historical Data

The historical data trend for Danaher's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danaher FCF Margin % Chart

Danaher Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

18.51

24.31

28.70

27.78

24.20

Danaher Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															28.26	22.02	19.02	45.19	24.98

Competitive Comparison of Danaher's FCF Margin %

For the Diagnostics & Research subindustry, Danaher's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Danaher's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Danaher's FCF Margin % falls into.

Danaher FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Danaher's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	5301.177	/	21907.13
	=	24.20 %

Danaher's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	1332.16	/	5332.32
	=	24.98 %

Danaher FCF Margin % Related Terms

Thank you for viewing the detailed overview of Danaher's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Danaher (FRA:DAP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Danaher Corp (FRA:DAP) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

DHR:USA DHR:Mexico 1DHR:Italy DAPd:UK DAP:Germany DHER34:Brazil DHRC:Austria

Address

2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, USA, 20037-1701

Website

https://www.danaher.com

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto.

Danaher (FRA:DAP) Headlines

No Headlines